A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval

Detalhes bibliográficos
Autor(a) principal: Coskun, Demet
Data de Publicação: 2011
Outros Autores: Gunaydin, Berrin, Tas, Ayca, Inan, Gozde, Celebi, Hulya, Kaya, Kadir
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/19558
Resumo: OBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-controlled propofol infusion at an effectsite concentration of 1.5 μg/mL was instituted. The patients were randomly allocated to receive remifentanil at an effect-site concentration of either 1.5 (group I, n = 23), 2 (group II, n = 23) or 2.5 ng/mL (group III, n = 23). Hemodynamic variables, sedation, pain, the Aldrete recovery score, and side effects were recorded. RESULTS: Hemodynamic variables, sedation and pain scores and the number of patients with the maximum Aldrete recovery score 10 min after the procedure were comparable among the groups. The number of patients in group III with the maximum Aldrete recovery score 5 min after the procedure was significantly lower than that in groups I and II. One patient in group II and one patient in group III suffered from nausea. CONCLUSION: Similar pain-free conscious sedation conditions without significant changes in hemodynamic parameters were provided by all three protocols. However, target controlled infusion of remifentanil at 1.5 or 2 ng/mL proved superior at providing early recovery compared to 2.5 ng/mL.
id USP-19_9f20212bf8821e6de21459eb2df4e682
oai_identifier_str oai:revistas.usp.br:article/19558
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval Target-Controlled InfusionPropofolRemifentanilOocyte RetrievalSedation OBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-controlled propofol infusion at an effectsite concentration of 1.5 μg/mL was instituted. The patients were randomly allocated to receive remifentanil at an effect-site concentration of either 1.5 (group I, n = 23), 2 (group II, n = 23) or 2.5 ng/mL (group III, n = 23). Hemodynamic variables, sedation, pain, the Aldrete recovery score, and side effects were recorded. RESULTS: Hemodynamic variables, sedation and pain scores and the number of patients with the maximum Aldrete recovery score 10 min after the procedure were comparable among the groups. The number of patients in group III with the maximum Aldrete recovery score 5 min after the procedure was significantly lower than that in groups I and II. One patient in group II and one patient in group III suffered from nausea. CONCLUSION: Similar pain-free conscious sedation conditions without significant changes in hemodynamic parameters were provided by all three protocols. However, target controlled infusion of remifentanil at 1.5 or 2 ng/mL proved superior at providing early recovery compared to 2.5 ng/mL. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1955810.1590/S1807-59322011000500017Clinics; v. 66 n. 5 (2011); 811-815 Clinics; Vol. 66 Núm. 5 (2011); 811-815 Clinics; Vol. 66 No. 5 (2011); 811-815 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/19558/21621Coskun, DemetGunaydin, BerrinTas, AycaInan, GozdeCelebi, HulyaKaya, Kadirinfo:eu-repo/semantics/openAccess2012-05-23T16:48:37Zoai:revistas.usp.br:article/19558Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-23T16:48:37Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
title A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
spellingShingle A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
Coskun, Demet
Target-Controlled Infusion
Propofol
Remifentanil
Oocyte Retrieval
Sedation
title_short A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
title_full A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
title_fullStr A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
title_full_unstemmed A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
title_sort A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
author Coskun, Demet
author_facet Coskun, Demet
Gunaydin, Berrin
Tas, Ayca
Inan, Gozde
Celebi, Hulya
Kaya, Kadir
author_role author
author2 Gunaydin, Berrin
Tas, Ayca
Inan, Gozde
Celebi, Hulya
Kaya, Kadir
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Coskun, Demet
Gunaydin, Berrin
Tas, Ayca
Inan, Gozde
Celebi, Hulya
Kaya, Kadir
dc.subject.por.fl_str_mv Target-Controlled Infusion
Propofol
Remifentanil
Oocyte Retrieval
Sedation
topic Target-Controlled Infusion
Propofol
Remifentanil
Oocyte Retrieval
Sedation
description OBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-controlled propofol infusion at an effectsite concentration of 1.5 μg/mL was instituted. The patients were randomly allocated to receive remifentanil at an effect-site concentration of either 1.5 (group I, n = 23), 2 (group II, n = 23) or 2.5 ng/mL (group III, n = 23). Hemodynamic variables, sedation, pain, the Aldrete recovery score, and side effects were recorded. RESULTS: Hemodynamic variables, sedation and pain scores and the number of patients with the maximum Aldrete recovery score 10 min after the procedure were comparable among the groups. The number of patients in group III with the maximum Aldrete recovery score 5 min after the procedure was significantly lower than that in groups I and II. One patient in group II and one patient in group III suffered from nausea. CONCLUSION: Similar pain-free conscious sedation conditions without significant changes in hemodynamic parameters were provided by all three protocols. However, target controlled infusion of remifentanil at 1.5 or 2 ng/mL proved superior at providing early recovery compared to 2.5 ng/mL.
publishDate 2011
dc.date.none.fl_str_mv 2011-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19558
10.1590/S1807-59322011000500017
url https://www.revistas.usp.br/clinics/article/view/19558
identifier_str_mv 10.1590/S1807-59322011000500017
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19558/21621
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; v. 66 n. 5 (2011); 811-815
Clinics; Vol. 66 Núm. 5 (2011); 811-815
Clinics; Vol. 66 No. 5 (2011); 811-815
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1787713174077702144